{"transactions":[{"id":4712,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-04T21:00:26.000Z","date":"2026-09-02","kind":"grant","planned":false,"acquired":true,"shares":1130400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant."}],"balance_after":1130400,"derivative":{"exercise_price":1,"expiration_date":"2036-09-02","underlying":"Common Stock","underlying_shares":1130400},"source":{"system":"sec-edgar","filing":"0001213900-26-097741","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1566175/000121390026097741/ownership.xml","form_type":"4"}},{"id":4711,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T21:00:26.000Z","date":"2026-09-02","kind":"grant","planned":false,"acquired":true,"shares":1027274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant of RSUs. These RSUs vest fully on the third anniversary of the date of grant."}],"balance_after":1965355,"source":{"system":"sec-edgar","filing":"0001213900-26-097741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566175/000121390026097741/ownership.xml","form_type":"4"}},{"id":4710,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T21:00:26.000Z","date":"2026-09-02","kind":"grant","planned":false,"acquired":true,"shares":753600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). These RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant."}],"balance_after":938081,"source":{"system":"sec-edgar","filing":"0001213900-26-097741","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566175/000121390026097741/ownership.xml","form_type":"4"}},{"id":1060047,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:00:25.000Z","date":"2025-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":120900,"price":1.71,"value":206739.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay Mr. Seth's tax withholding obligations incurred in connection with the vesting of 300,000 restricted stock units, or RSUs, on August 18, 2025. On August 17, 2022, Mr. Seth was granted an award of 300,000 RSUs, in exchange for warrants granted to Mr. Seth on December 17, 2012 for services provided to the Company prior to becoming employed by Actinium. The warrants were in the money since vesting on December 17, 2013. Mr. Seth refrained from exercising the warrants to be aligned with the long-term interests of the Company and stockholders. In November 2018, the Board extended the expiration of Mr. Seth's warrants to February 2022. In February 2022, the Company requested that Mr. Seth not exercise the warrants. In exchange, the Board determined to grant Mr. Seth 300,000 RSUs based on the average fair value of the warrants during their vested life to continue to align Mr. Seth with the long-term interest of the Company and stockholders."}],"balance_after":184481,"source":{"system":"sec-edgar","filing":"0001213900-25-079019","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025079019/ownership.xml","form_type":"4"}},{"id":1182795,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:20:52.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":984367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":5,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":984367},"source":{"system":"sec-edgar","filing":"0001213900-25-028226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028226/ownership.xml","form_type":"4"}},{"id":1182794,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:20:52.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":827366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":4.96,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":827366},"source":{"system":"sec-edgar","filing":"0001213900-25-028226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028226/ownership.xml","form_type":"4"}},{"id":1182793,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:20:52.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":310182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":6.07,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":310182},"source":{"system":"sec-edgar","filing":"0001213900-25-028226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028226/ownership.xml","form_type":"4"}},{"id":1182792,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:20:52.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":139062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":9.55,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":139062},"source":{"system":"sec-edgar","filing":"0001213900-25-028226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028226/ownership.xml","form_type":"4"}},{"id":1182791,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:20:52.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":6.96,"expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-25-028226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028226/ownership.xml","form_type":"4"}},{"id":1182790,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:20:52.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":23.49,"expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001213900-25-028226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028226/ownership.xml","form_type":"4"}},{"id":1182789,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:20:52.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":41.7,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-25-028226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028226/ownership.xml","form_type":"4"}},{"id":1182788,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:20:52.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":59.7,"expiration_date":"2026-04-15","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001213900-25-028226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028226/ownership.xml","form_type":"4"}},{"id":1697775,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-29T22:17:33.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":984367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested."}],"balance_after":984367,"derivative":{"exercise_price":5,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":984367},"source":{"system":"sec-edgar","filing":"0001213900-23-100063","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390023100063/ownership.xml","form_type":"4"}},{"id":2177990,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-19T20:55:13.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":305381,"source":{"system":"sec-edgar","filing":"0001213900-22-049737","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390022049737/ownership.xml","form_type":"4"}},{"id":2216798,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T23:13:09.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":827366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested."}],"balance_after":827366,"derivative":{"exercise_price":4.96,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":827366},"source":{"system":"sec-edgar","filing":"0001213900-22-036868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390022036868/ownership.xml","form_type":"4"}},{"id":2578642,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T21:01:40.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":310182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested."}],"balance_after":310182,"derivative":{"exercise_price":6.07,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":310182},"source":{"system":"sec-edgar","filing":"0001213900-21-046682","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390021046682/ownership.xml","form_type":"4"}},{"id":3057010,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-14T21:21:04.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":139062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested."}],"balance_after":139062,"derivative":{"exercise_price":9.55,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":139062},"source":{"system":"sec-edgar","filing":"0001213900-20-022341","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390020022341/ownership.xml","form_type":"4"}},{"id":3460571,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Options to purchase common stock","published_at":"2019-07-16T21:02:27.000Z","date":"2019-07-12","kind":"grant","acquired":true,"shares":1500000,"price":0.232,"value":348000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant."}],"balance_after":1500000,"derivative":{"exercise_price":0.232,"exercise_date":"2019-07-12","expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001213900-19-012875","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390019012875/ownership.xml","form_type":"4"}},{"id":3641267,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2019-02-21T21:45:01.000Z","date":"2019-02-21","kind":"other","acquired":true,"shares":8125,"price":0.6,"value":4875.0,"ownership":{"direct":true},"balance_after":161458,"source":{"system":"sec-edgar","filing":"0001213900-19-002982","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390019002982/ownership.xml","form_type":"4"}},{"id":3737259,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2018-12-10T21:14:06.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":10000,"price":0.4372,"value":4372.0,"ownership":{"direct":true},"balance_after":153333,"source":{"system":"sec-edgar","filing":"0001213900-18-017145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018017145/ownership.xml","form_type":"4"}},{"id":3865996,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Options to purchase common stock","published_at":"2018-07-17T21:13:12.000Z","date":"2018-07-13","kind":"grant","acquired":true,"shares":1000000,"price":0.7829,"value":782900.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant."}],"balance_after":1000000,"derivative":{"exercise_price":0.7829,"exercise_date":"2018-07-13","expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001213900-18-009317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018009317/ownership.xml","form_type":"4"}},{"id":3865995,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common stock","published_at":"2018-07-17T21:13:12.000Z","date":"2018-07-17","kind":"purchase","acquired":true,"shares":10000,"price":0.79,"value":7900.0,"ownership":{"direct":true},"balance_after":143333,"source":{"system":"sec-edgar","filing":"0001213900-18-009317","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018009317/ownership.xml","form_type":"4"}},{"id":3959161,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2018-04-20T20:15:18.000Z","date":"2018-04-19","kind":"purchase","acquired":true,"shares":5000,"price":0.38,"value":1900.0,"ownership":{"direct":true},"balance_after":133333,"source":{"system":"sec-edgar","filing":"0001213900-18-004773","document":"f4041918seth_actiniumpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018004773/f4041918seth_actiniumpharma.xml","form_type":"4"}},{"id":4004985,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Series B Warrants","published_at":"2018-03-08T21:35:38.000Z","date":"2018-03-06","kind":"other","acquired":true,"shares":39375,"price":0.5,"value":19687.5,"ownership":{"direct":true},"balance_after":39375,"derivative":{"exercise_price":0.7,"exercise_date":"2018-03-06","expiration_date":"2020-09-06","underlying":"Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001213900-18-002739","document":"f4030618seth_actiniumpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018002739/f4030618seth_actiniumpharm.xml","form_type":"4"}},{"id":4004984,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Series A Warrants","published_at":"2018-03-08T21:35:38.000Z","date":"2018-03-06","kind":"other","acquired":true,"shares":13125,"price":0.5,"value":6562.5,"ownership":{"direct":true},"balance_after":13125,"derivative":{"exercise_price":0.6,"exercise_date":"2018-03-06","expiration_date":"2019-03-06","underlying":"Common Stock","underlying_shares":13125},"source":{"system":"sec-edgar","filing":"0001213900-18-002739","document":"f4030618seth_actiniumpharm.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018002739/f4030618seth_actiniumpharm.xml","form_type":"4"}},{"id":4004983,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2018-03-08T21:35:38.000Z","date":"2018-03-06","kind":"other","acquired":true,"shares":52500,"price":0.5,"value":26250.0,"ownership":{"direct":true},"balance_after":128333,"source":{"system":"sec-edgar","filing":"0001213900-18-002739","document":"f4030618seth_actiniumpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018002739/f4030618seth_actiniumpharm.xml","form_type":"4"}},{"id":4242094,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-08-04T20:35:42.000Z","date":"2017-08-02","kind":"purchase","acquired":true,"shares":33333,"price":0.75,"value":24999.75,"ownership":{"direct":true},"balance_after":75833,"source":{"system":"sec-edgar","filing":"0001213900-17-008254","document":"f4080217seth_actiniumpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017008254/f4080217seth_actiniumpharm.xml","form_type":"4"}},{"id":4280395,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2017-06-15T20:54:16.000Z","date":"2017-06-15","kind":"purchase","acquired":true,"shares":5000,"price":1.16,"value":5800.0,"ownership":{"direct":true},"balance_after":42500,"source":{"system":"sec-edgar","filing":"0001213900-17-006529","document":"f4061517seth_actinium.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017006529/f4061517seth_actinium.xml","form_type":"4"}},{"id":4280394,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common stock","published_at":"2017-06-15T20:54:16.000Z","date":"2017-06-15","kind":"purchase","acquired":true,"shares":2500,"price":1.17,"value":2925.0,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001213900-17-006529","document":"f4061517seth_actinium.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017006529/f4061517seth_actinium.xml","form_type":"4"}},{"id":4382041,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to purchase common stock","published_at":"2017-03-16T20:36:38.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":750000,"price":1.39,"value":1042500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant. In addition, 100,000 options are subject to cancellation based on the obtainment of certain milestones."}],"balance_after":750000,"derivative":{"exercise_price":1.39,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001213900-17-002469","document":"f4031417sandesh_actinium.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017002469/f4031417sandesh_actinium.xml","form_type":"4"}},{"id":4382040,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant to purchase common stock","published_at":"2017-03-16T20:36:38.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":57212,"price":2.34,"value":133876.08,"ownership":{"direct":true},"balance_after":57212,"derivative":{"exercise_price":2.34,"exercise_date":"2017-03-14","expiration_date":"2022-02-11","underlying":"Common Stock","underlying_shares":57.212},"source":{"system":"sec-edgar","filing":"0001213900-17-002469","document":"f4031417sandesh_actinium.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017002469/f4031417sandesh_actinium.xml","form_type":"4"}},{"id":4382039,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant to purchase common stock","published_at":"2017-03-16T20:36:38.000Z","date":"2017-03-14","kind":"other","acquired":false,"shares":57212,"price":2.34,"value":133876.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Certain warrants were issued to Mr. Seth as part of investment banking and advisory services either prior to and outside of Mr. Seth's role as a Board Member and subsequently Executive Chairman and are not compensation for these latter services to the Company.  The Executive Chairman has refrained from exercising certain warrants that are or have been in the money for most of their term in order to align with the long term interests of the Company.  In order to maintain that alignment on March 14, 2017 the Company cancelled a Warrant in the amount of 57,212, shares and issued a new warrant with a term until February 11, 2022."}],"balance_after":0,"derivative":{"exercise_price":2.34,"exercise_date":"2012-01-19","expiration_date":"2018-01-28","underlying":"Common Stock","underlying_shares":57212},"source":{"system":"sec-edgar","filing":"0001213900-17-002469","document":"f4031417sandesh_actinium.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017002469/f4031417sandesh_actinium.xml","form_type":"4"}},{"id":4382038,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant to purchase common stock","published_at":"2017-03-16T20:36:38.000Z","date":"2017-03-14","kind":"other","acquired":true,"shares":99619,"price":0.78,"value":77702.82,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Certain warrants were issued to Mr. Seth as part of investment banking and advisory services either prior to and outside of Mr. Seth's role as a Board Member and subsequently Executive Chairman and are not compensation for Board or Executive Chairman services to the Company.  The Executive Chairman has refrained from exercising certain warrants that are or have been in the money for most of their term in order to align with the long term interests of the Company.  In order to maintain that alignment on March 14. 2017, the warrant was amended to extend the term until February 11, 2022. The warrant issued for 99,619 shares was issued to Amrosan LLC, an entity affiliated with Mr. Seth's family."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Certain warrants were issued to Mr. Seth as part of investment banking and advisory services either prior to and outside of Mr. Seth's role as a Board Member and subsequently Executive Chairman and are not compensation for Board or Executive Chairman services to the Company.  The Executive Chairman has refrained from exercising certain warrants that are or have been in the money for most of their term in order to align with the long term interests of the Company.  In order to maintain that alignment on March 14. 2017, the warrant was amended to extend the term until February 11, 2022. The warrant issued for 99,619 shares was issued to Amrosan LLC, an entity affiliated with Mr. Seth's family."}],"balance_after":99.619,"derivative":{"exercise_price":0.78,"exercise_date":"2012-01-31","expiration_date":"2022-02-11","underlying":"Common Stock","underlying_shares":99619},"source":{"system":"sec-edgar","filing":"0001213900-17-002469","document":"f4031417sandesh_actinium.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017002469/f4031417sandesh_actinium.xml","form_type":"4"}},{"id":4382037,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant to purchase common stock","published_at":"2017-03-16T20:36:38.000Z","date":"2017-03-14","kind":"other","acquired":true,"shares":64746,"price":0.78,"value":50501.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Certain warrants were issued to Mr. Seth as part of investment banking and advisory services either prior to and outside of Mr. Seth's role as a Board Member and subsequently Executive Chairman and are not compensation for Board or Executive Chairman services to the Company.  The Executive Chairman has refrained from exercising certain warrants that are or have been in the money for most of their term in order to align with the long term interests of the Company.  In order to maintain that alignment on March 14. 2017, the warrant was amended to extend the term until February 11, 2022. The warrant issued for 99,619 shares was issued to Amrosan LLC, an entity affiliated with Mr. Seth's family."}],"balance_after":64746,"derivative":{"exercise_price":0.78,"exercise_date":"2012-01-31","expiration_date":"2022-02-11","underlying":"Common Stock","underlying_shares":64.746},"source":{"system":"sec-edgar","filing":"0001213900-17-002469","document":"f4031417sandesh_actinium.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017002469/f4031417sandesh_actinium.xml","form_type":"4"}},{"id":4507278,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2017-01-03T13:00:57.000Z","date":"2016-12-30","kind":"purchase","acquired":true,"shares":5000,"price":0.88,"value":4400.0,"ownership":{"direct":true},"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001213900-17-000008","document":"f4123016seth_actiniumphar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390017000008/f4123016seth_actiniumphar.xml","form_type":"4"}},{"id":4525297,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10179,"kind":"person","name":"SETH SANDESH","position":1,"cik":"0001566175","reported_name":"SETH SANDESH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2016-12-12T21:44:18.000Z","date":"2016-12-12","kind":"purchase","acquired":true,"shares":5000,"price":0.98,"value":4900.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001213900-16-019329","document":"f4121216sandesh_actiniumphar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390016019329/f4121216sandesh_actiniumphar.xml","form_type":"4"}}]}